Frontline vs Sequenced Therapies in BCG-Unresponsive Bladder Cancer: What's the Best Approach?

6 Views
Published
In the fifth segment of this NMIBC roundtable, the panelists discuss the evolving landscape of bladder cancer treatments, focusing on balancing bladder-sparing therapies and timely radical cystectomy. The group explores the sequencing of emerging agents, the impact of treatment lines on efficacy, and practical considerations for patient counseling.

#bladdercancer #oncology #cancer #cancerresearch #urology #healthcare
Category
Oncology
Be the first to comment